Literature DB >> 24048722

Atypical femoral fractures: a review of the literature.

Pingal A Desai1, Parth A Vyas, Joseph M Lane.   

Abstract

Bisphosphonates are the most commonly used drugs worldwide for treating osteoporosis. Atypical femoral fractures most commonly are associated with prolonged bisphosphonate use. They also may occur with denosumab use or in patients without a history of using these drugs. In this article, we provide a comprehensive review of the mechanism of action of bisphosphonate and the definition, incidence, epidemiology, pathogenesis, diagnosis, management, and prevention of atypical femoral fractures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048722     DOI: 10.1007/s11914-013-0167-y

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  66 in total

1.  Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.

Authors:  Erich Durchschlag; Eleftherios P Paschalis; Ruth Zoehrer; Paul Roschger; Peter Fratzl; Robert Recker; Roger Phipps; Klaus Klaushofer
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

2.  Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women.

Authors:  Peter Peichl; Lukas A Holzer; Richard Maier; Gerold Holzer
Journal:  J Bone Joint Surg Am       Date:  2011-09-07       Impact factor: 5.284

3.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

4.  Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.

Authors:  Jane A Cauley; Dennis Black; Steven Boonen; Steven R Cummings; Peter Mesenbrink; Lisa Palermo; Zulema Man; Peyman Hadji; Ian R Reid
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

5.  Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.

Authors:  Stephen J Gomberg; Rosanna L Wustrack; Nicola Napoli; Claude D Arnaud; Dennis M Black
Journal:  J Clin Endocrinol Metab       Date:  2011-03-23       Impact factor: 5.958

6.  Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.

Authors:  S T Harris; E F Eriksen; M Davidson; M P Ettinger; A H Moffett; D J Baylink; C E Crusan; A A Chines
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

7.  Teriparatide improves early callus formation in distal radial fractures.

Authors:  Per Aspenberg; Torsten Johansson
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

Review 8.  Bone mineralization density distribution in health and disease.

Authors:  P Roschger; E P Paschalis; P Fratzl; K Klaushofer
Journal:  Bone       Date:  2007-11-12       Impact factor: 4.398

Review 9.  Bisphosphonate mechanism of action.

Authors:  Alfred A Reszka; Gideon A Rodan
Journal:  Curr Rheumatol Rep       Date:  2003-02       Impact factor: 4.686

10.  Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.

Authors:  M Saito; S Mori; T Mashiba; S Komatsubara; K Marumo
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 5.071

View more
  6 in total

Review 1.  Novel advances in the treatment of osteoporosis.

Authors:  Christopher K Y Chan; Alice Mason; Cyrus Cooper; Elaine Dennison
Journal:  Br Med Bull       Date:  2016-08-24       Impact factor: 4.291

2.  Bilateral atypical femoral fractures: how much symmetry is there on imaging?

Authors:  Linda Probyn; Angela M Cheung; Catherine Lang; Leon Lenchik; Jonathan D Adachi; Aliya Khan; Robert G Josse; George Tomlinson; Robert Bleakney
Journal:  Skeletal Radiol       Date:  2015-07-14       Impact factor: 2.199

3.  Atypical femoral fractures bilaterally in a patient receiving bisphosphonate: a case report.

Authors:  Alessandro Moghnie; Veronica Scamacca; Giovanni De Fabrizio; Roberto Valentini
Journal:  Clin Cases Miner Bone Metab       Date:  2016-05-11

Review 4.  Atypical femur fractures: a review.

Authors:  Wesley H Bronson; I David Kaye; Kenneth A Egol
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

5.  The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.

Authors:  Genki Kato; Yasuhiro Shimizu; Yuki Arai; Natsuki Suzuki; Yasutaka Sugamori; Miki Maeda; Mariko Takahashi; Yukihiko Tamura; Noriyuki Wakabayashi; Ramachandran Murali; Takashi Ono; Keiichi Ohya; Setsuko Mise-Omata; Kazuhiro Aoki
Journal:  Arthritis Res Ther       Date:  2015-09-12       Impact factor: 5.156

6.  Outcomes for Elderly Patients With Atypical Femoral Fractures Compared to Typical Femoral Fractures for Length of Stay, Discharge Destination, and 30-Day Mortality Rate.

Authors:  Dominic Davenport; James Duncan; Robert Duncan; Alastair Dick; Mohit Bansal; Max R Edwards
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.